The stock of Zimmer Biomet Holdings, Inc. (ZBH) shows potential growth given its presence in the orthopedic reconstructive market. With a diverse range of products and a global market reach, ZBH has promising aspects. However, potential investors should be mindful of the competitive nature of the healthcare device industry.
The fundamental analysis indicates a solid position in the market, although improvement is needed in debt management.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 4 |
When comparing current and past scores, ZBH retains stability in cash flow and returns, necessitating attention to debt strategy.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-07-02 | 3 | 5 | 3 | 3 | 1 | 2 | 4 |
| N/A | 0 | 5 | 3 | 3 | 1 | 2 | 4 |
The stock price target range suggests varied expectations with a consensus to hold.
| High | Low | Median | Consensus |
|---|---|---|---|
| 120 | 83 | 93 | 96.33 |
Analysis shows a predominant recommendation to hold, with more conservative buy suggestions.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 21 | |
| Sell | 3 | |
| Strong Sell | 0 |
Zimmer Biomet Holdings, Inc. presents a stable investment in the medical devices sector with notable strengths in product diversity and market presence. The company retains a solid footing in cash flow and returns, though its debt management remains a potential risk. The relative stability in analyst ratings and price targets suggests a cautious optimism, yet investors should weigh industry competition. A moderate to long-term holding could be considered, given ongoing investments in innovation and global market expansion.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.